Epigenetic mechanisms in COPD: implications for pathogenesis and drug discovery.
about
Early injury of the neonatal lung contributes to premature lung aging: a hypothesisImmunology, genetics and microbiota in the COPD pathophysiology: potential scope for patient stratification.Bronchial epithelial cells: The key effector cells in the pathogenesis of chronic obstructive pulmonary disease?The Intersection Of Aging Biology and The Pathobiology of Lung Diseases: A Joint NHLBI/NIA Workshop.Functional AdoMet Isosteres Resistant to Classical AdoMet Degradation Pathways.The EGFR-ADAM17 Axis in Chronic Obstructive Pulmonary Disease and Cystic Fibrosis Lung Pathology.
P2860
Epigenetic mechanisms in COPD: implications for pathogenesis and drug discovery.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Epigenetic mechanisms in COPD: implications for pathogenesis and drug discovery.
@en
type
label
Epigenetic mechanisms in COPD: implications for pathogenesis and drug discovery.
@en
prefLabel
Epigenetic mechanisms in COPD: implications for pathogenesis and drug discovery.
@en
P2093
P2860
P1476
Epigenetic mechanisms in COPD: implications for pathogenesis and drug discovery.
@en
P2093
Andrea C Schamberger
Nikica Mise
Oliver Eickelberg
Silke Meiners
P2860
P304
P356
10.1517/17460441.2014.913020
P407
P577
2014-06-01T00:00:00Z